›› 2014, Vol. 29 ›› Issue (1): 49-49.DOI: 10.3969/j.issn.1673-8640.2014.01.011
Previous Articles Next Articles
Received:2013-07-03
Online:2014-01-20
Published:2014-01-20
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2014.01.011
| [1] 薛声能, 程 桦. 糖化血红蛋白的研究进展[J]. 国际内科学杂志, 2008, 35(10): 586-588. [2] International Federation of Clinical Chemistry and Laboratory Medicine, IFCC Scientific Division, Nordin G, et al. Recommendation for term and measurement unit for "HbA1c" [J]. Clin Chem Lab Med, 2007, 45(8): 1081-1082. [3] Pradhan AD, Rifai N, Buring JE , et al. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women[J]. Am J Med, 2007, 120(8): 720-727. [4] Sarwar N, Aspelund T, Eiriksdottir G, et al. Markers of dysglycaemia and risk of coronary heart disease in people without diabetes:Reykjavik prospective study and systematic review[J]. PLoS Med, 2010, 7(5): e1000278. [5] Kramer CK, von Mühleu D, Gross JL, et al. Blood pressure and fasting plasma glucose rather than metabolic syndrome predict coronary artery calcium pro-gssion:the Rancho Bernardo Study[J]. Diabetes Care, 2009, 32(1):141-146. [6] Voidonikola PT, Stamatelopoulos KS, Alevizaki M, et al.The association between glycemia and endothelial function in nondiabetic individuals:the importance of body weight[J].Obesity(Silver Spring), 2008, 16(12): 2658-2662. [7] Imanaka S.Epidemiological study on HbA1c 1evel below 6.1％ among community residents and follow-up study of HbA1c level-clinical significance of health examination(Japan)in the aged members from the view point of glucose metabolism[J].Nihon Ronel Igakkai Zasshi, 2011, 48(3): 271-275. [8] 朱馨媛, 郭彩霞, 徐晓微, 等.非糖尿病患者血清HbA1c与冠心病的相关性研究[J]. 山东医药, 2010, 50(17): 83-84. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
